A plasma-based assay for assessment of tumour mutational burden in patients with metastatic non-small cell lung cancer in the first-line treatment setting: Results from the MYSTIC study

2019 ◽  
Vol 110 ◽  
pp. S2
Author(s):  
H. Si ◽  
M. Kuziora ◽  
E. Helman ◽  
K. Quinn ◽  
P.Z. Brohawn ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Treatment Setting ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
Mutational Burden ◽  
First Line Treatment

Pemetrexed approved for the first-line treatment of non-small-cell lung cancer: summary of the NICE appraisal

2009 ◽  
Vol 10 (11) ◽  
pp. 1031-1032 ◽  
Author(s):  
Panagiota Vrouchou ◽  
Prashanth Kandaswamy ◽  
Elisabeth George ◽  
David Barnett
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document